How are human molecular genetic studies of addiction defined?
A3. Human molecular genetic studies of addiction are defined as research projects that identify chromosomal loci and genetic variation in genes that are hypothesized to be associated with abuse (including initiation) of, addiction to, or dependence on stimulants (e.g., cocaine and amphetamine), narcotics (e.g., opiates), nicotine, benzodiazepines, barbiturates, cannabis, hallucinogens, and/or multiple drugs of abuse in humans. Q4. Is NGC membership available to investigators doing other human genetic studies of drug addiction such as twin studies and adoption studies that are not aimed at identifying specific genetic factors? A4. No. Only investigators conducting the human molecular genetics of drug addiction research are eligible for NGC membership. Such studies aim to identify gene variants and chromosomal regions associated with drug addiction and are collecting biomaterials containing DNA. NGC meetings, however, are open to any researcher interested in attending. Please contact NID
Related Questions
- Are all principal investigators of NIDA-funded grants studying the human molecular genetics of addiction encouraged to join the NGC?
- Are all NIDA-funded investigators studying the human molecular genetics of addiction encouraged to join the NGC?
- How are human molecular genetic studies of addiction defined?
